UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934*
Acorda Therapeutics, Inc.
-------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
----------------------------------------
(Title of Class of Securities)
00484M106
---------
(CUSIP Number)
September 26, 2006
------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
---------------------------------- ------------------------
CUSIP No. 00484M106 13G Page 2 of 10 Pages
---------------------------------- ------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Third Point LLC
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,000,000
OWNED BY
EACH ------ -----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0
------ -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,000,000
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,000
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.7%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
OO
---------- ---------------------------------------------------------------------
---------------------------------- ------------------------
CUSIP No. 00484M106 13G Page 3 of 10 Pages
---------------------------------- ------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Daniel S. Loeb
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,000,000
OWNED BY
EACH ------ -----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0
------ -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,000,000
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,000
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.7%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
---------- ---------------------------------------------------------------------
---------------------------------- ------------------------
CUSIP No. 00484M106 13G Page 4 of 10 Pages
---------------------------------- ------------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Third Point Offshore Fund, Ltd.
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
-------------------- ------ ----------------------------------------------------
5 SOLE VOTING POWER
0
------ ----------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,315,500
OWNED BY
EACH ------ -----------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0
------ -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,315,500
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,315,500
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.8%
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
OO
---------- ---------------------------------------------------------------------
Item 1(a): Name of Issuer:
--------- --------------
The name of the issuer is Acorda Therapeutics, Inc., a corporation organized
under the laws of the State of Delaware (the "Company").
Item 1(b): Address of Issuer's Principal Executive Offices:
--------- -----------------------------------------------
The Company's principal executive office is located at 15 Skyline Drive,
Hawthorne, New York 10532.
Item 2(a): Name of Person Filing:
--------- ---------------------
This Schedule 13G is filed by:
(i) Third Point LLC, a Delaware limited liability company (the
"Management Company"), which serves as investment manager or adviser
to a variety of hedge funds and managed accounts (such funds and
accounts, collectively, the "Funds"), with respect to shares of
Common Stock (as defined in Item 2(d)) directly owned by the Funds;
and
(ii) Mr. Daniel S. Loeb ("Mr. Loeb"), who is the Chief Executive Officer
of the Management Company and controls its business activities, with
respect to shares of Common Stock indirectly beneficially owned by
Mr. Loeb by virtue of such position.
(iii) Third Point Offshore Fund, Ltd., a Cayman Islands limited liability
exempted company (the "Offshore Fund") which invests and trades in
securities, with respect to shares of Common Stock directly
beneficially owned by it.
The Management Company, Mr. Loeb and the Offshore Fund are hereinafter sometimes
collectively referred to as the "Reporting Persons." Any disclosures herein with
respect to persons other than the Reporting Persons are made on information and
belief after making inquiry to the appropriate party.
Item 2(b): Address of Principal Business Office or, if None, Residence:
--------- -----------------------------------------------------------
The address of the principal business office of the Management Company and Mr.
Loeb is 390 Park Avenue, 18th Floor, New York, New York 10022. The address of
the principal business office of the Offshore Fund is c/o Walkers SPV Limited,
Walker House, Mary Street, P.O. Box 908GT, George Town, Grand Cayman, Cayman
Islands, British West Indies.
Item 2(c): Citizenship:
--------- -----------
The Management Company is organized as a limited liability company under the
laws of the State of Delaware. Mr. Loeb is a United States citizen. The Offshore
Fund is organized as a limited liability exempted company under the laws of the
Cayman Islands.
- 5 -
Item 2(d): Title of Class of Securities:
--------- ----------------------------
Common Stock, par value $0.001 ("Common Stock").
Item 2(e): CUSIP Number:
--------- ------------
00484M106.
Item 3: If this statement is filed pursuant to Rules 13d-1(b) or
------ --------------------------------------------------------
13d-2(b) or (c), check whether the person filing is a:
-----------------------------------------------------
A. [ ] Broker or dealer registered under Section 15 of the Act,
B. [ ] Bank as defined in Section 3(a)(6) of the Act,
C. [ ] Insurance Company as defined in Section 3(a)(19) of the Act,
D. [ ] Investment Company registered under Section 8 of the
Investment Company Act of 1940,
E. [ ] Investment Adviser in accordance with Rule 13d-1
(b)(1)(ii)(E),
F. [ ] Employee Benefit Plan or Endowment Fund in accordance with
13d-1 (b)(1)(ii)(F),
G. [ ] Parent Holding Company or control person in accordance with
Rule 13d-1 (b)(1)(ii)(G),
H. [ ] Savings Association as defined in Section 3(b) of the Federal
Deposit Insurance Act,
I. [ ] Church Plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act of 1940,
J. [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4: Ownership:
------ ----------
The beneficial ownership of Common Stock by the Reporting Persons, as of the
date of this Schedule 13G, is as follows:
A. Third Point LLC
---------------
(a) Amount beneficially owned: 2,000,000
(b) Percent of class: 8.7%. The percentages used herein and in the rest
of this Schedule 13G are calculated based upon a total of 22,861,405 shares of
Common Stock issued and outstanding, based upon (i) the 19,630,636 shares of
Common Stock issued and outstanding as of June 30, 2006, as reflected in the
Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30,
2006, and (ii) the 3,230,769 shares of Common Stock issued on October 6, 2006,
in a private placement of Common Stock.
(c) Number of shares as to which such person has:
(i) Sole power to vote or direct the vote: 0
(ii) Shared power to vote or direct the vote: 2,000,000
(iii) Sole power to dispose or direct the disposition: 0
(iv) Shared power to dispose or direct the disposition: 2,000,000
- 6 -
B. Daniel S. Loeb
--------------
(a) Amount beneficially owned: 2,000,000
(b) Percent of class: 8.7%.
(c) Number of shares as to which such person has:
(i) Sole power to vote or direct the vote: 0
(ii) Shared power to vote or direct the vote: 2,000,000
(iii) Sole power to dispose or direct the disposition: 0
(iv) Shared power to dispose or direct the disposition: 2,000,000
C. Third Point Offshore Fund, Ltd.
-------------------------------
(a) Amount beneficially owned: 1,315,500
(b) Percent of class: 5.8%.
(c) Number of shares as to which such person has:
(i) Sole power to vote or direct the vote: 0
(ii) Shared power to vote or direct the vote: 1,315,500
(iii) Sole power to dispose or direct the disposition: 0
(iv) Shared power to dispose or direct the disposition: 1,315,500
Item 5: Ownership of Five Percent or Less of a Class:
------ --------------------------------------------
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following: [ ]
Item 6: Ownership of More than Five Percent on Behalf of Another Person:
------ ---------------------------------------------------------------
Other than as set forth herein, no other person has the right to receive or the
power to direct the receipt of dividends from, or proceeds from the sale of, in
excess of 5% of the total outstanding Common Stock.
Item 7: Identification and Classification of the Subsidiary Which
------ ---------------------------------------------------------
Acquired the Security Being Reported on by the Parent Holding
-------------------------------------------------------------
Company:
-------
Not applicable.
Item 8: Identification and Classification of Members of the Group:
------ ---------------------------------------------------------
Not applicable.
Item 9: Notice of Dissolution of Group:
------ ------------------------------
Not applicable.
- 7 -
Item 10: Certification:
------- -------------
Each of the Reporting Persons hereby makes the following certification:
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
- 8 -
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: October 6, 2006
THIRD POINT LLC
By: /s/ Daniel S. Loeb
------------------------------------------
Name: Daniel S. Loeb
Title: Chief Executive Officer
THIRD POINT OFFSHORE FUND, LTD.
By: /s/ Daniel S. Loeb
------------------------------------------
Name: Daniel S. Loeb
Title: Chief Executive Officer
By: /s/ Daniel S. Loeb
------------------------------------------
Daniel S. Loeb
[SIGNATURE PAGE TO SCHEDULE 13G WITH RESPECT TO
ACORDA THERAPEUTICS, INC.]
EXHIBIT INDEX
-------------
Exhibit 99.1: Joint Filing Agreement, dated October 6, 2006, by and between
Third Point LLC, Daniel S. Loeb and Third Point Offshore Fund,
Ltd.